Glycyrrhizin prevents of lipopolysaccharide/D-galactosamine-induced liver injury through down-regulation of matrix metalloproteinase-9 in mice
- PMID: 18251086
- PMCID: PMC7166488
- DOI: 10.1211/jpp.60.1.0012
Glycyrrhizin prevents of lipopolysaccharide/D-galactosamine-induced liver injury through down-regulation of matrix metalloproteinase-9 in mice
Abstract
Glycyrrhizin, a biological active compound isolated from the liquorice root, has been used as a treatment for chronic hepatitis. We have examined the involvement of matrix metalloproteinase (MMP)9 in the development of lipopolysaccharide (LPS) and D-galactosamine (GalN)-induced liver injury in mice. We also investigated the effect of glycyrrhizin on expression of MMP-9 in this model. Levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) increased after LPS/ GalN treatment. Expression of MMP-9 mRNA and protein was markedly up-regulated in liver tissues 6-8 h after LPS/GalN treatment. Pretreatment with glycyrrhizin (50 mg kg(-1)) and the MMP inhibitor (5 mg kg(-1)) suppressed increases in serum levels of ALT and AST in mice treated with LPS/GalN. Furthermore, glycyrrhizin inhibited levels of both mRNA and protein for MMP-9. Immunohistochemical reaction for MMP-9 was observed in macrophages/monocytes infiltrated in the inflammatory area of liver injury. Glycyrrhizin reduced the infiltration of inflammatory cells and immunoreactive MMP- 9 in liver injury. The results indicated that MMP-9 played a role in the development of LPS/GalN- induced mouse liver injury, and suggested that an inhibition by glycyrrhizin of the acute liver injury may have been due to a down-regulation of MMP-9.
References
-
- Arase, Y. , Ikeda, K. , Murashima, N. , Chayama, K. , Tsubota, A. , Koida, I. , Suzuki, Y. , Saitoh, S. , Kobayashi, M. , Kumada, H. (1997) The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 79: 1494–1500. - PubMed
-
- Chosay, J. S. , Essani, N. A. , Dunn, C. J. , Jaeschke, H. (1997) Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin‐induced injury. Am. J. Physiol. 272: G1195–G1200. - PubMed
-
- Endo, Y. , Shibazaki, M. , Yamaguchi, K. , Kai, K. , Sugawara, S. , Takada, H. , Kikuchi, H. , Kumagai, K. (1999) Enhancement by galactosamine of lipopolysaccharide (LPS)‐induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment. Br. J. Pharmacol. 128: 5–12. - PMC - PubMed
-
- Ikeda, K. , Arase, Y. , Kobayashi, M. , Saitoh, S. , Someya, T. , Hosaka, T. , Sezaki, H. , Akuta, N. , Suzuki, Y. , Suzuki, F. , Kumada, H. (2006) A long‐term glycyrrhizin injection therapy reduces hepato‐cellular carcinogenesis rate in patients with interferon‐resistant active chronic hepatitis C: a cohort study of 1249 patients. Dig. Dis. Sci. 51: 603–609. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
